Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEER
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,938
Award facts
- Contract value 100% obligated
- $14,938.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,938.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support Department of Defense medical operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) established through the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.9 million ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for military healthcare facilities worldwide. The contractor's extensive product portfolio includes oncology treatments, immunosuppressants, biologics, vaccines, emergency medications, and surgical products, positioning it as a key provider for recurring medical supply needs across the Department of Defense's global healthcare operations. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FEEER?
SPE2DU26FEEER was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DU26FEEER worth?
The government has obligated $14,938 on SPE2DU26FEEER.
Is contract SPE2DU26FEEER an order under another contract?
Yes. SPE2DU26FEEER is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEER competed?
The extent of competition for SPE2DU26FEEER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award